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Assisted reproduction technologies require ovarian stimulation to increase the 17 
number of oocytes and embryos. Currently, superstimulation is achieved by 18 
gonadotropin treatment, but the embryo yield and quality are highly variable. 19 
Commonly, commercial preparations derived from pituitary and urinary origin are 20 
used to superovulate. Hence, ovarian superstimulation protocols have usually 21 
included both FSH and LH. The appearance of recombinant gonadotropins 22 
manufactured by genetic engineering techniques has ensured high quality and batch-23 
to-batch consistency. Moreover, this enables us to assess the importance of LH in 24 
the ovarian stimulation. The main aim of this study was to evaluate the effect of 25 
recombinant human LH supplementation (10%) on embryonic development produced 26 
by rabbit does superovulated with low or high concentration (18.75 or 37.50 IU) of 27 
recombinant human FSH (rhFSH). Females treated with rhFSH increased the 28 
ovulation rate, and it was significantly higher when the high FSH dose was 29 
supplemented with LH. The superstimulation treatment used did not significantly 30 
affect in vitro development rate until the expanded blastocyst stage. The results of 31 
this study seem to suggest that, in terms of superovulatory response, when rabbit 32 
does are treated with 37.5-IU rhFSH, the use of LH supplementation allows an 33 
increase in the number of follicles recruited and the quality of embryos, in terms of 34 
ability to develop in vitro until blastocyst, and the expression profile of OCT4, 35 
NANOG, and SOX2 genes is not affected. 36 
 37 






Superstimulation of females from domestic animals is used to augment conventional 43 
genetic improvement pro- grams and facilitates advances in reproductive bio- 44 
technologies. Rabbit presents great interest as an experimental animal model for 45 
biomedical research, genetic modeling, and fur and meat production [1,2]. Super- 46 
stimulation is considered a fundamental method to estab- lish an abundant source of 47 
oocytes and embryos and requires the administration of exogenous gonadotropin. 48 
Although is well established that FSH alone can induce follicular growth, small 49 
amounts of LH are necessary to support the follicular development [3,4]. The action 50 
of LH on follicular development is not limited to providing androgen substrate for 51 
aromatization but also exerts a direct effect on the stimulation and modulation of 52 
folliculogenesis [5,6], and the influence and the amount of LH necessary for optimal 53 
follicular stimulation is still being investigated. Until recently, superovulation 54 
treatments in farm mammals were based on the use of eCG and FSH preparations 55 
derived from pituitary extracts (porcine, ovine, or equine), in which the variable LH 56 
concentration present may interfere the FSH activity [7,8], and it is one of the most 57 
important factors for the variability in the superstimulation response, affecting the 58 
ability of the ovary to respond to exogenous gonado- tropin treatments. The use of 59 
pituitary-derived products presents other problems including contamination from 60 
other hormones, inconsistencies within and among batches, and the possibility of the 61 
spread of disease-transmitting agents [8]. Several studies have attributed detrimental 62 
effects of an excessive LH content on follicular development, but these studies have 63 
not established an optimal dose of LH or an optimal ratio FSH:LH to maximize the 64 
super- stimulation response [9–11]. In rabbits, the effect of LH on superstimulation 65 
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has been studied using porcine FSH, obtaining highly variable results [11,12]. 66 
Because of break- throughs in recombinant technology, it is possible to easily 67 
dispose of LH and FSH in an isolated manner, which facili- tates the study of the role 68 
of LH in ovarian response. 69 
 70 
On the other hand, the usual parameters to evaluate embryo quality are the 71 
morphologic appearance at recov- ery or the blastocyst rate after IVC. However, it 72 
has been reported that messenger RNA (mRNA) expression is related with the 73 
embryo quality [13–18]. In addition, the early steps in embryo development can be 74 
affected by the culture media and conditions as well as the production procedure 75 
itself, which alters gene expression [13,14,16,19–21]. Therefore, the evaluation of 76 
gene expression may help assess the developmental quality of the embryos. It is 77 
known that the transcription factor octamer-binding 4 (OCT4), NANOG homeobox 78 
(NANOG), and sex- determining region Y-box 2 (SOX2) have essential roles in early 79 
development and are considered key regulators of the pluripotency maintenance 80 
system [22]. Thus, changes in their expression might trigger failures in embryo devel- 81 
opment and implantation. The implications of super- stimulation experience acquired 82 
in animal studies and its possible short-term and long-term consequences should be 83 
taken into account when proposing gonadotropin treat- ment to increase the number 84 
of oocytes or embryos pro- duced for reproductive biotechnologies. 85 
 86 
This study aimed to evaluate the relative importance of LH in ovarian stimulation with 87 
recombinant human FSH (rhFSH) and the effect on the development ability of 88 
embryos in vitro and the expression of transcription factors OCT4, SOX2, and 89 
NANOG. 90 
 5 
2. MATERIAL AND METHODS 91 
 92 
Unless stated otherwise, all chemicals in this study were purchased from 93 
Sigma-Aldrich Química S.A (Madrid, Spain). The proteomic analysis was carried out 94 
in the CSIE_university of Valencia Proteomics Unit, a member of ISCIII ProteoRed 95 
Proteomics Platform.  96 
 97 
 98 
2.1. Animals 99 
All animals were handled according to the principles of animal care published by 100 
Spanish Royal Decree 53/2013 in the Official Spanish State Gazette (Boletín Oficial 101 
del Estado) in 2013.The research was carried out at the experimental farm of the 102 
Universidad Politécnica de Valencia. Forty-three nulliparous does and five bucks of 103 
sexually mature New Zealand White rabbits were used. Animals were housed in flat-104 
deck cages, fed a standard pellet diet ad libitum, and had free access to water. An 105 
alternating cycle of 16-hour light and 8-hour dark was used [23]. 106 
 107 
2.2. Hormonal treatment 108 
Superstimulation was induced using rhFSH (GONAL-f 75; Serono Europe Ltd., 109 
London, UK) alone or in combination with recombinant human LH (rhLH; Luveris 75; 110 
Serono Europe Ltd.). Does were treated intramuscularly with either 18.75 or 37.50 IU 111 
rhFSH alone or in combination with 10% rhLH (1.87 and 3.75 IU, respectively) 112 
dissolved in saline distributed in five equal doses at 12-hour intervals. Females were 113 
assigned randomly to five treatment groups: 114 
 115 
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1. Control: females were not superstimulated but were treated with saline solution. 116 
2. Low FSH: superstimulation was induced using 18.75-IU rhFSH. 117 
3. Low FSH–LH: superstimulation was induced using 18.75-IU rhFSH þ 10% rhLH 118 
(1.87 IU). 119 
4. High FSH: superstimulation was induced using 37.50-IU rhFSH. 120 
5. High FSH–LH: superstimulation was induced using 37.50-IU rhFSH þ 10% rhLH 121 
(3.75 IU). 122 
 123 
Does were inseminated with 0.5 mL of fresh heterospermic pool 10 to 12 hours after 124 
the last gonadotropin injection. To prepare the heterospermic pool, ejaculates from 125 
five males were collected using an artificial vagina. The 10-mL aliquot samples from 126 
ejaculates were diluted 1:10 with a Tris-citrate-glucose extender (250-mM 127 
Tris(hydroxymethyl)aminomethane, 83-mM citric acid, 50-mM glucose, pH 6.8–7.0, 128 
300 mOsm/kg) for a prior motility rate evaluation. Ejaculates with an estimated 129 
motility higher than 70% were pooled. From heterospermic pool, two aliquot samples 130 
of 10 mL were taken; the first one was diluted 1:10 with the Tris-citrate-glucose 131 
extender for motility rate evaluation in a computer-assisted analysis system, and the 132 
second was diluted 1:10 with 1% of glutaraldehyde solution in PBS to calculate the 133 
concentra- tion in a Thoma chamber and evaluate both the percent- ages of normal 134 
intact acrosome and abnormal sperm by phase contrast at a magnification of 400. 135 
Only hetero- spermic pools with more than 70% of motility rate, 85% of normal intact 136 
acrosome, and less than 15% of abnormal sperm were used to inseminate the does. 137 
Pooled semen was diluted to 40 million/mL by adding Tris-citrate-glucose extender to 138 
prepare the seminal doses. Does were induced to ovulate with an intramuscularly 139 
administration of 1-mg buserelin acetate at the same time as the insemination. 140 
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2.3. Embryo recovery 141 
Females were slaughtered 38 to 40 hours after artificial insemination with an 142 
intravenous injection of 0.6-g pentobarbital sodium (Dolethal; Vetoquinol, Madrid, 143 
Spain), and the reproductive tract was immediately removed. Embryos were 144 
recovered by perfusion of each oviduct with 5-mL Dulbecco’s PBS without 145 
calcium2.3.1. Seminal plasma preparation chloride and supplemented with 0.1% of 146 
BSA. Embryos were scored by morphologic criteria according to Interna- tional 147 
Embryo Transfer Society classification. Only embryos in the eight- to 16-cell stage 148 
without morphologic abnor- malities in mucin coat, ZP, and embryo cells were 149 
cataloged as normal embryos (Fig. 1). 150 
The ovulation rate, number of embryos, and number of oocytes were 151 
recorded. The recovery rate was calculated as the number of embryos and oocytes 152 
recovered divided by the ovulation rate, multiplied by 100. The fertilization rate was 153 
calculated as the number of embryos divided by the number of embryos and oocytes 154 
recovered, multiplied by 100. 155 
 156 
2.4. In vitro culture 157 
A total of 429 embryos were cultured for 48 hours in medium TCM-199 158 
(Sigma, St. Louis, MO, USA) supple- mented with 10% fetal bovine serum and 159 
antibiotics (penicillin G sodium, 300,000 IU; penicillin G procaine, 700,000 IU; and 160 
dihydrostreptomycin sulfate, 1250 mg; Penivet 1; Divasa Farmavic, Barcelona, 161 
Spain) at 38.5  C, 5% CO2, and saturated humidity. The in vitro development ability 162 
of embryos until blastocyst stage was recorded for subsequent analysis (Fig. 1). 163 
2.5. RNA extraction and quantitative PCR analysis 164 
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PolyA RNA was extracted from pools consisting of 13 to 15 embryos using the 165 
Dynabeads kit (Life Technologies, Carlsbad, CA, USA), following the manufacturer’s 166 
in- structions. Six independent embryo pools were produced for each experimental 167 
group. Then, reverse transcription was carried out using SuperScript III Reverse 168 
Transcriptase (Life Technologies AS, Oslo, Norway) according to the manufacturer’s 169 
instructions. Real-time polymerase chain reaction (PCR) reactions were conducted in 170 
an Applied Biosystems 7500 system (Applied Biosystems). Every PCR was 171 
performed from 5-mL diluted 1:10 complementary DNA (cDNA) template, 250-nM of 172 
forward and reverse specific primers (Table 1), and 10 mL of Power SYBR Green 173 
PCR Master Mix (Fermentas Gmbh, Madrid, Spain) in a final volume of 20 mL. The 174 
PCR protocol included an initial step of 50   C (2 minutes), followed by 95   C (10 175 
minutes), and 42 cycles of 95  C (15 seconds) and 60  C (30 seconds). After 176 
quantitative PCR, a melting curve analysis was performed by slowly increasing the 177 
temperature from 65   C to 95   C, with continuous recording of changes in 178 
fluorescent emission intensity. To avoid detection of genomic DNA (gDNA), at least 179 
one primer per pair was designed to span an exon–exon boundary. All the primers 180 
were tested on gDNA and RNA to confirm that potentially contaminant gDNA was not 181 
amplified. The specificity was confirmed by melting curve analysis, gel 182 
electrophoresis, and sequencing of the quantitative PCR products. Serial dilutions of 183 
cDNA pool made from several samples were done to assess PCR efficiency. A ddCt 184 
method adjusted for PCR efficiency was used, using the geometric average of 185 
H2AFZ (H2A histone family member Z [24]) and GAPDH (glyceraldehyde- 3-186 
phosphate dehydrogenase [25]) as a housekeeping normalization factor [26]. 187 
Relative expression of cDNA pool from various samples was used as the calibrator to 188 
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normalize all samples within one PCR run or between several runs. SOX2 data were 189 
normalized by a Napierian logarithm transformation. 190 
 191 
2.6. Statistical analysis 192 
The effect of superstimulation treatment (control, low FSH, low FSH–LH, high FSH, 193 
or high FSH–LH) on the ovulation rate, number of recovered embryos, recovery rate, 194 
and fertilization rate was analyzed by ANOVA using a general linear model 195 
procedure. For the developmental rate, a probit link with binomial error distribution 196 
was used. Data of relative mRNA abundance were normalized by a Napierian 197 
logarithm transformation and analyzed using a general linear model. All statistical 198 
analyses were performed with SPSS software (SPSS 16.0 software pack- age; SPSS 199 
Inc., 2002, Chicago, IL, USA). Results were reported as least-square means with 200 
standard error of the mean. Means were separated using Fisher’s protected least 201 




3. RESULTS 206 
Effects of superstimulation treatments on recovery variables are shown in 207 
Table 2. All the females treated with rhFSH increased the ovulation rate. However, 208 
the lack of statistical difference among the low FSH concentration groups and control 209 
may be due to the small sample size. Ovulation rate in high FSH concentration 210 
groups was significantly higher than that in the control group. Addi- tionally, the 211 
ovulation rate was significantly higher when the high FSH dose was supplemented 212 
with LH. The number of recovered embryos showed a similar evolution to the 213 
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ovulation rate. A clear trend toward an increase in the number of recovered embryos 214 
was observed in FSH-treated females, although there was no significant difference 215 
among low FSH groups and the control. The high FSH groups showed significantly 216 
higher numbers of recovered embryos than the control group, although the results 217 
from high and low FSH groups without LH supplement were not statistically different. 218 
The recovery rate was not affected by superstimulation treatment. Finally, the 219 
fertilization rate 220 
was significant decreased in the low FSH group supplemented with LH. 221 
As shown in Table 3, the superstimulation treatment did not significantly affect 222 
in vitro development rate until the expanded blastocyst stage. The proportion of 223 
embryo development was very high. 224 
Results of superstimulation treatment on embryos OCT4, NANOG, and SOX2 225 
gene expression are shown in Figure 2. No significant differences among relative 226 
values of OCT4, NANOG, and SOX2 gene expression from different superstimulation 227 
treatment were detected. 228 
 229 
4. DISCUSSION 230 
In the present study, the ovulation rates of females treated with 37.50-IU 231 
rhFSH supplemented with 10% rhLH were 3.5 times higher than those observed for 232 
the control group and twice of those observed for 18.75-IU rhFSH alone or with 10% 233 
rhLH groups. Similar results were reported by Ju et al. [27] with porcine FSH. 234 
Nevertheless, the undefined LH concentration present in pituitary extract used by 235 
these authors hampered the comparison of trials. In women, an LH concentration 236 
window has been described [6,28] below which estradiol production is not adequate 237 
and above which LH may be detrimental to follicular development. In a work 238 
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designed to simplify hormone administration and reduce the stress of treatment and 239 
animal handling in rabbits, 25-IU rhFSH alone or in combination with rhLH was 240 
diluted in a slow-release polymer (polyvinylpyrrolidone). It was shown that the 241 
superovulatory response of does with 242 
 243 
the rhFSH dose used was not dependent on rhLH supple- mentation [29], and 244 
it was concluded that the endogenous LH concentration in rabbits seemed enough to 245 
duplicate the ovulation rate of does treated with this FSH dose. A similar ovulation 246 
rate was reported previously by other authors using FSH from pituitary glands 247 
[11,12,30,31]. Therefore, results of the present work showed that 37.50-IU rhFSH 248 
supplemented with 3.75-IU rhLH treatment was significantly more efficient than the 249 
other treatments tested, showing an ovulation rate and a number of embryos 250 
recovered three times higher than control females. During a normal follicular wave, 251 
subordinate follicles regress because of decreasing concentration of circulating FSH. 252 
Small follicles require FSH to continue their growth. In the superstimulation protocol, 253 
the depressed endogenous FSH caused by the secretory products of dominant 254 
follicles is replaced by exogenous FSH. However, a larger number of recruited 255 
follicles implies an increase in the LH require- ment of mural granulosa cells and, 256 
consequently, a higher level of circulating FSH would result in an increased de- mand 257 
of LH as a requirement to improve the number of follicles recruited. Ovulation rate 258 
observed with 37.50-IU rhFSH was significantly higher when it was supple- mented 259 
with 3.75-IU rhLH. It seems that endogenous LH levels from females treated with 260 
37.5-IU rhFSH alone were insufficient to increase follicular recruitment to the values 261 
achieved when this concentration of FSH was sup- plemented with LH. This suggests 262 
that the window of LH in rabbits is FSH dose dependent, and the higher the con- 263 
 12 
centration of FSH used, the more the LH window shifts to higher concentrations. 264 
When the FSH concentration used is low, 10% of LH supplement may exceed the LH 265 
requirements and the fertilization and embryonic devel- opment is negatively 266 
affected. In contrast, when the FSH concentration used is high, 10% of LH 267 
supplementation is essential to increase the number of recruited follicles dur- ing the 268 
selection phase. These results are in agreement with a study in women using rFSH 269 
and rLH which suggest that LH actually sensitizes follicles to FSH and thereby 270 
encour- ages follicular development and hormone secretion. In this study, the 271 
number of developing follicles was much reduced or delayed in the group treated 272 
with a fixed dose of rFSH without rLH [3]. The present findings seem to be consistent 273 
with those of Filicori et al. [32], who found variable effects of LH and FSH on follicles 274 
of different sizes. They showed that FSH alone affected the growth dynamic of small 275 
follicles and the LH supplementation affected the medium or large follicles, 276 
suggesting that expression of LH receptors may provide an additional source of 277 
follicular support. In fact, at nonsaturating concentrations of FSH and LH, the 278 
response is additive. Therefore, once the appro- priate stage of follicular 279 
development in response to treatment with FSH is reached, granulosa cells become 280 
receptive to LH stimulation and LH becomes capable of exerting its actions on both 281 
theca and granulosa cells [33]. 282 
Regarding embryo quality, to provide a more complete idea of the 283 
development potential of the embryos in the present work, in addition to the in vitro 284 
development ability of embryos, the OCT4, NANOG, and SOX2 gene expressions 285 
were studied. Results of the present work showed that embryo quality, in terms of 286 
ability to develop in vitro from 287 
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eight- to 16-cell stage to the blastocyst stage and OCT4, NANOG, and SOX2 288 
gene expression, was not affected by superovulation treatment, with results similar to 289 
nontreated females. In cows, it was shown that hormonal superstimulation with 290 
porcine or ovine FSH, with high and low LH percentage, respectively, may affect the 291 
mRNA profile of some genes [20,34]. Mundim et al. [20] showed differences in gene 292 
expression profile of a group of genes related to embryo development between 293 
superovulated and control embryos, but no differences were observed compared to 294 
embryos produced in vitro. Chu et al. [34] observed that although the number of 295 
genes influenced seemed low, the mRNA expression profile of potential fac- tors of 296 
developmental competence in the bovine oocyte was affected by follicular 297 
stimulation. It is necessary to study whether the source of FSH may affect the 298 
expression profile of these genes. 299 
In conclusion, results from the present study showed that the treatment of 300 
rabbit does with 37.5-IU rhFSH alone or supplemented with rhLH was effective in 301 
stimulating superovulation without affecting the embryos ability to develop in vitro 302 
until blastocyst and the embryonic expression of OCT4, NANOG, and SOX2 genes. 303 
On the other hand, the present study suggests that the rhLH supple- mentation at 304 
this rhFSH concentration increased the number of follicles recruited and the 305 
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